HO SUE SAN @ DAVID HO SUE SAN
Chairman and Managing Director
Mr David Ho is the Managing Director of the Company. He was appointed to the Board, being the first Director since incorporation of the Company on 20 May 1980 and was redesignated to Chairman and Managing Director on 31 January 2008. Mr David Ho obtained a Bachelor of Pharmacy degree from the University of Otago, Dunedin, New Zealand, in 1974. He later obtained a Master of Pharmacy degree from the University of Otago in 1976. He was registered as a pharmacist with the Pharmaceutical Society of New Zealand in 1974 and as a pharmaceutical chemist by the Pharmaceutical Society of Great Britain in 1977. He was registered as a pharmacist with the Malaysian Pharmacist Board in 1980. He has also completed the Applied International Management Programme organised by the Swedish Institute of Management in 1990 and the International Top Management Seminar in the field of Quality Leadership organised by ISO Swedish Management Group in 1996. From 1978 to 1979, he was a research pharmacist with Wyeth Laboratories Ltd. Thereafter, he formed and incorporated Hovid Berhad in 1980. He was on the Board of Malaysian Biotechnology Corporation Sdn. Bhd., a subsidiary of MOF Inc in Malaysia from 2006 to 2009. Additionally, he is a major shareholder of the Company as at 30 June 2018.
Mr David Ho has attended all the five (5) Board meetings held during the financial year ended 30 June 2018
HO, SARAH, LEE-MUN
Ms Ho, Sarah, Lee-Mun was appointed to the board of the Company on 1 September 2017 as an Executive Director. She holds a Master of business administrative from Hong Kong University of Science and Technology and a bachelor of Pharmacy (Hons) from University of Auckland in New Zealand. She is a licenced pharmacist with the Pharmaceutical Society of New Zealand with over 9 years of experience in the healthcare industry, ranging from pharmacy practice in the retail environment, to sales, marketing and operations. She started her career in retail pharmacy and has since then progressed into the pharmaceutical industry in sales and marketing. She was appointed as Head of Sales and Marketing of Hovid Group on 1 July 2016, a position she holds till todate. She was appointed as an Executive Director of Hovid Pharmacy Sdn. bhd., a wholly-owned subsidiary of Hovid berhad on 30 June 2017.
Her father, Ho Sue San @ David Ho Sue San, is the Managing Director and major shareholder of the Company.
Ms Sarah Ho has attended four (4) Board meetings held during the financial year ended 30 June 2018, since her appointment to the Board on 1 September 2017.